Top news
Merck says experimental Covid pill cuts risk of death, hospitalization by 50 percent
By Erika Edwards
Molnupiravir, a drug developed by Merck, could be the first oral antiviral medicine for covid-19
By Carolyn Johnson
Coronavirus: Covid News: U.S. Parents' Views Are Shifting on Vaccines (Published 2021)
By Benjamin Mueller, Shawn Hubler & Rebecca Robbins
All coverage
Fauci sees hope in new Merck drug
By Quint Forgey
New antiviral drug prevents half of severe COVID-19 infections
By Karen Weintraub
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
By Manojna Maddipatla & Lewis Krauskopf
Merck Pill Intended to Treat Covid-19 Succeeds in Key Study
By Betsy McKay & Jared S. Hopkins
What would an antiviral pill mean for the fight against Covid-19?
By Virginia Langmaid
How Merck's antiviral pill could change the game for COVID-19
By Meryl Davids Landau